nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevelamer—Intestinal obstruction—Thiotepa—urinary bladder cancer	0.03	0.03	CcSEcCtD
Sevelamer—Ileus—Thiotepa—urinary bladder cancer	0.0289	0.0289	CcSEcCtD
Sevelamer—Faecaloma—Epirubicin—urinary bladder cancer	0.0288	0.0288	CcSEcCtD
Sevelamer—Faecalith—Epirubicin—urinary bladder cancer	0.0288	0.0288	CcSEcCtD
Sevelamer—Faecaloma—Doxorubicin—urinary bladder cancer	0.0266	0.0266	CcSEcCtD
Sevelamer—Faecalith—Doxorubicin—urinary bladder cancer	0.0266	0.0266	CcSEcCtD
Sevelamer—Flatulence—Valrubicin—urinary bladder cancer	0.0254	0.0254	CcSEcCtD
Sevelamer—Intestinal perforation—Methotrexate—urinary bladder cancer	0.0222	0.0222	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.0192	0.0192	CcSEcCtD
Sevelamer—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.0172	0.0172	CcSEcCtD
Sevelamer—Pain—Carboplatin—urinary bladder cancer	0.0167	0.0167	CcSEcCtD
Sevelamer—Abdominal pain—Valrubicin—urinary bladder cancer	0.0166	0.0166	CcSEcCtD
Sevelamer—Asthenia—Valrubicin—urinary bladder cancer	0.0151	0.0151	CcSEcCtD
Sevelamer—Pruritus—Valrubicin—urinary bladder cancer	0.0149	0.0149	CcSEcCtD
Sevelamer—Diarrhoea—Valrubicin—urinary bladder cancer	0.0144	0.0144	CcSEcCtD
Sevelamer—Anorexia—Mitomycin—urinary bladder cancer	0.0138	0.0138	CcSEcCtD
Sevelamer—Vomiting—Valrubicin—urinary bladder cancer	0.0134	0.0134	CcSEcCtD
Sevelamer—Rash—Valrubicin—urinary bladder cancer	0.0133	0.0133	CcSEcCtD
Sevelamer—Dermatitis—Valrubicin—urinary bladder cancer	0.0132	0.0132	CcSEcCtD
Sevelamer—Decreased appetite—Mitomycin—urinary bladder cancer	0.0126	0.0126	CcSEcCtD
Sevelamer—Nausea—Valrubicin—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Sevelamer—Fatigue—Mitomycin—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Sevelamer—Pain—Mitomycin—urinary bladder cancer	0.0124	0.0124	CcSEcCtD
Sevelamer—Ileus—Epirubicin—urinary bladder cancer	0.0116	0.0116	CcSEcCtD
Sevelamer—Ileus—Doxorubicin—urinary bladder cancer	0.0107	0.0107	CcSEcCtD
Sevelamer—Asthenia—Mitomycin—urinary bladder cancer	0.0104	0.0104	CcSEcCtD
Sevelamer—Diarrhoea—Mitomycin—urinary bladder cancer	0.00991	0.00991	CcSEcCtD
Sevelamer—Vomiting—Mitomycin—urinary bladder cancer	0.00921	0.00921	CcSEcCtD
Sevelamer—Rash—Mitomycin—urinary bladder cancer	0.00914	0.00914	CcSEcCtD
Sevelamer—Dermatitis—Mitomycin—urinary bladder cancer	0.00913	0.00913	CcSEcCtD
Sevelamer—Nausea—Mitomycin—urinary bladder cancer	0.00861	0.00861	CcSEcCtD
Sevelamer—Arthralgia—Thiotepa—urinary bladder cancer	0.0076	0.0076	CcSEcCtD
Sevelamer—Anorexia—Thiotepa—urinary bladder cancer	0.00695	0.00695	CcSEcCtD
Sevelamer—Flatulence—Cisplatin—urinary bladder cancer	0.0069	0.0069	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00664	0.00664	CcSEcCtD
Sevelamer—Dyspepsia—Thiotepa—urinary bladder cancer	0.00641	0.00641	CcSEcCtD
Sevelamer—Arthralgia—Gemcitabine—urinary bladder cancer	0.00639	0.00639	CcSEcCtD
Sevelamer—Decreased appetite—Thiotepa—urinary bladder cancer	0.00633	0.00633	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00629	0.00629	CcSEcCtD
Sevelamer—Fatigue—Thiotepa—urinary bladder cancer	0.00628	0.00628	CcSEcCtD
Sevelamer—Pain—Thiotepa—urinary bladder cancer	0.00623	0.00623	CcSEcCtD
Sevelamer—Constipation—Thiotepa—urinary bladder cancer	0.00623	0.00623	CcSEcCtD
Sevelamer—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00596	0.00596	CcSEcCtD
Sevelamer—Anorexia—Gemcitabine—urinary bladder cancer	0.00584	0.00584	CcSEcCtD
Sevelamer—Abdominal pain—Thiotepa—urinary bladder cancer	0.00576	0.00576	CcSEcCtD
Sevelamer—Anorexia—Fluorouracil—urinary bladder cancer	0.00574	0.00574	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00558	0.00558	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00549	0.00549	CcSEcCtD
Sevelamer—Anorexia—Cisplatin—urinary bladder cancer	0.00545	0.00545	CcSEcCtD
Sevelamer—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00533	0.00533	CcSEcCtD
Sevelamer—Dyspepsia—Fluorouracil—urinary bladder cancer	0.0053	0.0053	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00529	0.00529	CcSEcCtD
Sevelamer—Fatigue—Gemcitabine—urinary bladder cancer	0.00528	0.00528	CcSEcCtD
Sevelamer—Constipation—Gemcitabine—urinary bladder cancer	0.00524	0.00524	CcSEcCtD
Sevelamer—Pain—Gemcitabine—urinary bladder cancer	0.00524	0.00524	CcSEcCtD
Sevelamer—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00524	0.00524	CcSEcCtD
Sevelamer—Asthenia—Thiotepa—urinary bladder cancer	0.00523	0.00523	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.0052	0.0052	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.0052	0.0052	CcSEcCtD
Sevelamer—Abdominal distension—Epirubicin—urinary bladder cancer	0.00519	0.00519	CcSEcCtD
Sevelamer—Pruritus—Thiotepa—urinary bladder cancer	0.00515	0.00515	CcSEcCtD
Sevelamer—Pain—Fluorouracil—urinary bladder cancer	0.00515	0.00515	CcSEcCtD
Sevelamer—Anorexia—Etoposide—urinary bladder cancer	0.00499	0.00499	CcSEcCtD
Sevelamer—Diarrhoea—Thiotepa—urinary bladder cancer	0.00499	0.00499	CcSEcCtD
Sevelamer—Decreased appetite—Cisplatin—urinary bladder cancer	0.00497	0.00497	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00493	0.00493	CcSEcCtD
Sevelamer—Pain—Cisplatin—urinary bladder cancer	0.00489	0.00489	CcSEcCtD
Sevelamer—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00481	0.00481	CcSEcCtD
Sevelamer—Vomiting—Thiotepa—urinary bladder cancer	0.00463	0.00463	CcSEcCtD
Sevelamer—Rash—Thiotepa—urinary bladder cancer	0.00459	0.00459	CcSEcCtD
Sevelamer—Dermatitis—Thiotepa—urinary bladder cancer	0.00459	0.00459	CcSEcCtD
Sevelamer—Decreased appetite—Etoposide—urinary bladder cancer	0.00455	0.00455	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00452	0.00452	CcSEcCtD
Sevelamer—Fatigue—Etoposide—urinary bladder cancer	0.00451	0.00451	CcSEcCtD
Sevelamer—Constipation—Etoposide—urinary bladder cancer	0.00448	0.00448	CcSEcCtD
Sevelamer—Pain—Etoposide—urinary bladder cancer	0.00448	0.00448	CcSEcCtD
Sevelamer—Asthenia—Gemcitabine—urinary bladder cancer	0.0044	0.0044	CcSEcCtD
Sevelamer—Pruritus—Gemcitabine—urinary bladder cancer	0.00434	0.00434	CcSEcCtD
Sevelamer—Nausea—Thiotepa—urinary bladder cancer	0.00433	0.00433	CcSEcCtD
Sevelamer—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00428	0.00428	CcSEcCtD
Sevelamer—Pruritus—Fluorouracil—urinary bladder cancer	0.00426	0.00426	CcSEcCtD
Sevelamer—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00419	0.00419	CcSEcCtD
Sevelamer—Abdominal pain—Etoposide—urinary bladder cancer	0.00414	0.00414	CcSEcCtD
Sevelamer—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00412	0.00412	CcSEcCtD
Sevelamer—Asthenia—Cisplatin—urinary bladder cancer	0.0041	0.0041	CcSEcCtD
Sevelamer—Diarrhoea—Cisplatin—urinary bladder cancer	0.00391	0.00391	CcSEcCtD
Sevelamer—Vomiting—Gemcitabine—urinary bladder cancer	0.0039	0.0039	CcSEcCtD
Sevelamer—Rash—Gemcitabine—urinary bladder cancer	0.00386	0.00386	CcSEcCtD
Sevelamer—Dermatitis—Gemcitabine—urinary bladder cancer	0.00386	0.00386	CcSEcCtD
Sevelamer—Vomiting—Fluorouracil—urinary bladder cancer	0.00383	0.00383	CcSEcCtD
Sevelamer—Rash—Fluorouracil—urinary bladder cancer	0.0038	0.0038	CcSEcCtD
Sevelamer—Dermatitis—Fluorouracil—urinary bladder cancer	0.0038	0.0038	CcSEcCtD
Sevelamer—Asthenia—Etoposide—urinary bladder cancer	0.00376	0.00376	CcSEcCtD
Sevelamer—Pruritus—Etoposide—urinary bladder cancer	0.0037	0.0037	CcSEcCtD
Sevelamer—Nausea—Gemcitabine—urinary bladder cancer	0.00364	0.00364	CcSEcCtD
Sevelamer—Vomiting—Cisplatin—urinary bladder cancer	0.00363	0.00363	CcSEcCtD
Sevelamer—Rash—Cisplatin—urinary bladder cancer	0.0036	0.0036	CcSEcCtD
Sevelamer—Dermatitis—Cisplatin—urinary bladder cancer	0.0036	0.0036	CcSEcCtD
Sevelamer—Diarrhoea—Etoposide—urinary bladder cancer	0.00358	0.00358	CcSEcCtD
Sevelamer—Nausea—Fluorouracil—urinary bladder cancer	0.00358	0.00358	CcSEcCtD
Sevelamer—Flatulence—Epirubicin—urinary bladder cancer	0.00354	0.00354	CcSEcCtD
Sevelamer—Nausea—Cisplatin—urinary bladder cancer	0.00339	0.00339	CcSEcCtD
Sevelamer—Vomiting—Etoposide—urinary bladder cancer	0.00333	0.00333	CcSEcCtD
Sevelamer—Rash—Etoposide—urinary bladder cancer	0.0033	0.0033	CcSEcCtD
Sevelamer—Dermatitis—Etoposide—urinary bladder cancer	0.0033	0.0033	CcSEcCtD
Sevelamer—Flatulence—Doxorubicin—urinary bladder cancer	0.00328	0.00328	CcSEcCtD
Sevelamer—Arthralgia—Methotrexate—urinary bladder cancer	0.00327	0.00327	CcSEcCtD
Sevelamer—Nausea—Etoposide—urinary bladder cancer	0.00311	0.00311	CcSEcCtD
Sevelamer—Arthralgia—Epirubicin—urinary bladder cancer	0.00306	0.00306	CcSEcCtD
Sevelamer—Anorexia—Methotrexate—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Sevelamer—Arthralgia—Doxorubicin—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Sevelamer—Anorexia—Epirubicin—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Sevelamer—Dyspepsia—Methotrexate—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Sevelamer—Decreased appetite—Methotrexate—urinary bladder cancer	0.00273	0.00273	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Sevelamer—Fatigue—Methotrexate—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Sevelamer—Pain—Methotrexate—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00267	0.00267	CcSEcCtD
Sevelamer—Anorexia—Doxorubicin—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Sevelamer—Dyspepsia—Epirubicin—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Sevelamer—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Sevelamer—Decreased appetite—Epirubicin—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Sevelamer—Fatigue—Epirubicin—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Sevelamer—Pain—Epirubicin—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Sevelamer—Constipation—Epirubicin—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Sevelamer—Abdominal pain—Methotrexate—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Sevelamer—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Sevelamer—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Sevelamer—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Sevelamer—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Sevelamer—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Sevelamer—Fatigue—Doxorubicin—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Sevelamer—Constipation—Doxorubicin—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Sevelamer—Pain—Doxorubicin—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Sevelamer—Abdominal pain—Epirubicin—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Sevelamer—Asthenia—Methotrexate—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Sevelamer—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Sevelamer—Pruritus—Methotrexate—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Sevelamer—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Sevelamer—Diarrhoea—Methotrexate—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Sevelamer—Asthenia—Epirubicin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Sevelamer—Pruritus—Epirubicin—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Sevelamer—Diarrhoea—Epirubicin—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Sevelamer—Vomiting—Methotrexate—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Sevelamer—Rash—Methotrexate—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Sevelamer—Dermatitis—Methotrexate—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Sevelamer—Asthenia—Doxorubicin—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Sevelamer—Pruritus—Doxorubicin—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Sevelamer—Vomiting—Epirubicin—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Sevelamer—Nausea—Methotrexate—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Sevelamer—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Sevelamer—Rash—Epirubicin—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Sevelamer—Dermatitis—Epirubicin—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Sevelamer—Nausea—Epirubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Sevelamer—Vomiting—Doxorubicin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Sevelamer—Rash—Doxorubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Sevelamer—Dermatitis—Doxorubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Sevelamer—Nausea—Doxorubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
